Kolexia
Schved Jean-Francois Médecine interne
Schved Jean-Francois
Médecine interne
Hôpital Saint-Éloi
Montpellier, France
183 Activités
485 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hémophilie A Hémorragie Déficit en facteur VII Thrombose Hémophilie B Prédisposition génétique à une maladie Troubles de l'hémostase et de la coagulation Troubles hémorragiques Urgences

Collaborateurs

Voir plus
Giansily-Blaizot Muriel
Giansily-Blaizot Muriel
Hôpital Saint-Éloi, Montpellier, France
Susen Sophie
Susen Sophie
Centre de Biologie - Pathologie, Lille, France
Biron Christine
Biron Christine
Hôpital Saint-Éloi, Montpellier, France
Laroche Jean-Pierre
Laroche Jean-Pierre
Cabinet libéral, Avignon, France

Industries

Voir plus
Sobi
3 collaboration(s)
Dernière en 2020
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database.
Blood advances   29 janvier 2024
Surgery in rare bleeding disorders: the prospective MARACHI study.
Research and practice in thrombosis and haemostasis   06 septembre 2023
Post-viral idiopathic purpura fulminans is associated with inherited thrombophilia and anti-cardiolipin antibodies.
Frontiers in pediatrics   30 mai 2023
APOLD1 loss causes endothelial dysfunction involving cell junctions, cytoskeletal architecture, and Weibel-Palade bodies, while disrupting hemostasis.
Haematologica   01 mars 2023
Prospective, Non-interventional Study to Evaluate the Effectiveness of Elocta Compared to Conventional Factor Products: 24-month Prospective, Multicentre, Non-interventional Study to Evaluate the Effectiveness of Elocta Compared to Conventional Factor Products in the Prophylactic Treatment of Patients With Haemophilia A (A-SURE)
Essai Clinique (Sobi)   13 février 2023
Le sang: mythes, tabous et religion
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine   17 août 2022
LR-01.02 (1159194) Safety of eptacog beta: Comparing the 225 μg/kg and 75 μg/kg dosing regimens across pivotal clinical trials
Abstracts of the World Federation of Hemophilia World Congress 2022, 8–11 May 2022, Montreal and Virtual   25 avril 2022
PP-30 (1159191) Pain relief with Eptacog Beta in haemophilia patients with inhibitors
Abstracts of the World Federation of Hemophilia World Congress 2022, 8–11 May 2022, Montreal and Virtual   25 avril 2022
Idiopathic purpura fulminans associated with anti-protein S antibodies in children: a multicenter case series and systematic review.
Blood advances   11 avril 2022
Global Seroprevalence of Pre-existing Immunity Against AAV5 and Other AAV Serotypes in People with Hemophilia A.
Human gene therapy   16 mars 2022